Antimicrobial Stewardship

Antimicrobial stewardship is the coordinated set of activities that aims to optimise how antimicrobial agents are used—getting the right agent to the patient who needs it while minimising harm and the selection of resistance. It links individual treatment to the population-level goal of preserving these drugs.

Definition

Antimicrobial stewardship is a coherent set of coordinated actions designed to promote the responsible and appropriate use of antimicrobial agents, with the aim of improving patient outcomes, reducing adverse effects, and limiting the emergence and spread of antimicrobial resistance.

Scope

This topic covers the concept and rationale of stewardship, its core interventions, and its place between individual care and public health. It is a conceptual reference describing what stewardship programmes do; it does not provide prescribing rules or treatment regimens.

Core questions

• What is the goal of antimicrobial stewardship and whom does it serve?
• What core interventions do stewardship programmes use?
• How does stewardship balance the individual patient against the wider population?
• How is the effectiveness of stewardship assessed?

Key concepts

• Appropriate and responsible antimicrobial use
• Preauthorisation and prospective audit with feedback
• De-escalation and review of therapy
• Multidisciplinary stewardship teams
• Balancing individual benefit against population resistance
• Surveillance and outcome measurement

Mechanisms

Stewardship works through coordinated interventions rather than a single drug action. Core strategies described in practice guidelines include preauthorisation of selected agents and prospective audit of therapy with feedback to prescribers, supported by review and de-escalation of treatment as more information becomes available, and by measurement of use and outcomes. These activities are typically delivered by a multidisciplinary team. The defining tension of stewardship is that it must serve the individual patient—who should receive effective therapy—while also protecting the wider population by limiting the selection pressure that drives resistance.

Clinical relevance

Stewardship is the organisational response to antimicrobial resistance and is increasingly a standard feature of hospitals and health systems. This entry explains the concept and its components; it is not a prescribing protocol, and the specific interventions of any programme follow institutional policy and current guidelines.

Epidemiology

The case for stewardship rests on the global scale of antimicrobial resistance, which broad reviews have documented and linked to patterns of antimicrobial use; this evidence underpins the adoption of stewardship programmes across healthcare settings worldwide.

Evidence & guidelines

The IDSA/SHEA guideline sets out recommended stewardship interventions, and narrative reviews define the concept and summarise its rationale and components. These guidelines are voluntary recommendations, cannot account for every individual patient, and are periodically updated.

History

Concern about misuse of antibiotics is decades old, but stewardship coalesced into a defined discipline in the early twenty-first century as resistance became recognised as a systemic threat; professional societies subsequently issued formal guidelines for implementing stewardship programmes.

Seminal works

• laxminarayan-2013
• barlam-2016
• dyar-2017

Frequently asked questions

Is antimicrobial stewardship just about using fewer antibiotics?

No; it is about using antimicrobials appropriately—the right agent for the patient who needs it, for the right duration—which sometimes means treating and sometimes means avoiding or stopping treatment, with the dual aim of helping the patient and limiting resistance.

Who carries out antimicrobial stewardship?

It is typically delivered by a multidisciplinary team within a hospital or health system, using coordinated interventions such as audit with feedback and review of therapy, guided by professional society recommendations.